Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Letrozole monotherapy in advanced breast cancer
NCT00237198Phase 2Completed
- Sponsor
- Novartis
- Start
- Mar 2004
- Primary completion
- Jul 2006
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of letrozole in breast cancer, sponsored by Novartis. Started Mar 2004; status: completed.
02
Drugs
letrozole
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00237198.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00237198.